CHM chimeric therapeutics limited

Ann: CORE NK Platform Phase 1 Clinical Data Presentation, page-35

  1. 7,795 Posts.
    lightbulb Created with Sketch. 907
    The patient you speak of had a stem cell transplant (unrelated to CHM) as part of their treatment. How can you suggest that their recovery is as a result of CHM’s treatment?


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 90000 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 1864652 2
View Market Depth
Last trade - 09.49am 24/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.